Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 2, 2014CephalalgiaOpen Access

Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains

View Full Paper
Ask AI
Bookmark
Share

Authors

RBRami BursteinBeth Israel Deaconess Medical CenterXZXiChun ZhangCapital UniversityDLDan LevyHadassah Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Burstein et al. (2014) studied this question.

synapsesocial.com/papers/6a8aab537f5a142c17c1559chttps://doi.org/10.1177/0333102414527648
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Population-Based Analysis of the Diagnostic Criteria of the International Headache Society1991 · 298 citations
  2. 2Constitutive cycling: A general mechanism to regulate cell surface proteins2002 · 86 citations
  3. 3THE SYNAPTIC VESICLE CYCLE2004 · 2,518 citations
  4. 4Electrophysiological Properties of Dural Afferents in the Absence and Presence of Inflammatory Mediators2009 · 57 citations
  5. 5Dural afferents express acid-sensing ion channels: A role for decreased meningeal pH in migraine headache2010 · 104 citations